Marrone Bio Innovations, Inc Closes $9.2 Million Public Offering Of Common Stock With Full Exercise Of Over-Allotment Option Post author:Sam Post published:April 30, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like FDA Green Lights Pfizer Drug for Rare, Fast-Killing Type of Leukemia August 17, 2017 Ramaswamy's Roivant Inks $650M R&D Deal With This Tiny Diabetes Biotech February 11, 2018 Little-Known Synthorx Names Former Cleave CEO as New Leader November 27, 2017